Cite

APA Citation

    Dietrich, P., Wick, W., Hilf, N., Frenzel, K., Gouttefangeas, C., Platten, M., thor Straten, P., Lassen, U., Rodon, J., Bukur, V., Admon, A., van der Burg, S. H., von Deimling, A., Kroep, J. R., Martinez-Ricarte, F., Okada, H., Ottensmeier, C. H., Ponsati, B., Poulsen, H. S., Stevanovic, S., Tabatabai, G., Rammensee, H., Sahin, U., Singh-Jasuja, H., & ,  (n.d.). oS2.2 Highly personalized peptide vaccination for patients with newly diagnosed glioblastoma: the GAPVAC trial. Neuro-oncology, 20, iii219. http://access.bl.uk/ark:/81055/vdc_100095324532.0x00001e
  
Back to record